Zobrazeno 1 - 10
of 334
pro vyhledávání: ''
Autor:
Thea P. Lillethorup, Anna Sophie Thue Hvilsom, Anne M. Landau, Peter Iversen, Doris J. Doudet, Gregers Wegener
Publikováno v:
Hvilsom, A S T, Lillethorup, T P, Iversen, P, Doudet, D J, Wegener, G & Landau, A M 2019, ' Cortical and striatal serotonin transporter binding in a genetic rat model of depression and in response to electroconvulsive stimuli ', European Neuropsychopharmacology, vol. 29, no. 4, pp. 493-500 . https://doi.org/10.1016/j.euroneuro.2019.02.009
Depression is a debilitating mental illness and two thirds of patients respond insufficiently to conventional antidepressants. Electroconvulsive therapy (ECT) remains the most effective treatment to alleviate drug-refractory depression, however the n
Publikováno v:
Pharmacology Biochemistry and Behavior. 103:643-651
Major depression is a complex multi-factorial disorder with a lifetime diagnosis of nearly 1 out of 6. We used the Flinders Sensitive Line (FSL) of rats, a model of depression, and the parent Sprague-Dawley (SD) rats to identify genes, gene ontology
Publikováno v:
Pharmacology Biochemistry and Behavior. 99:487-499
In rats, 2,3,7,8-tetrachlorodibenzo- p -dioxin (TCDD) causes anorexia that may lead to fatal wasting but has hitherto been poorly characterized. Therefore, we studied in-depth feeding and drinking behaviors of TCDD-sensitive L–E rats for 5 (100 μg
Autor:
Michelle A. Collins, Robert N. Hughes
Publikováno v:
Pharmacology Biochemistry and Behavior. 94:534-542
Middle-aged 330-day-old male and female hooded rats were group-housed for nearly 5 months in either standard cages, or in cages containing objects. Each cage also provided either pure water, or a solution of vitamin E (DL-alpha-tocopherol acetate) fo
Publikováno v:
Pharmacology Biochemistry and Behavior. 55:475-480
The present study investigated the effects of perinatal flumazenil (Ro 15-1788, a benzodiazepine receptor antagonist), given from gestational day 15 to the 14th day after giving birth, at two doses (3.5 and 6.3 mg/kg/ day) on the behavior of female R
Publikováno v:
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35, 854-876
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35, 4, pp. 854-876
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35, 4, pp. 854-876
Item does not contain fulltext A great number of clinical observations show a relationship between epilepsy and depression. Idiopathic generalized epilepsy, including absence epilepsy, has a genetic basis. The review provides evidence that WAG/Rij ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db6ec5cc1d04a9376578779da2ed9680
https://doi.org/10.1016/j.pnpbp.2010.11.010
https://doi.org/10.1016/j.pnpbp.2010.11.010
Autor:
A.B. Keith, A. Sahgal
Publikováno v:
Pharmacology Biochemistry and Behavior. 45:995-1001
Rats were trained on a delayed nonmatching to position task, divided into four groups and given the following lesions: (a) SHAM (vehicle injection into nucleus basilis magnocellularis (NBM) and raphe nuclei (RN), (b) RN (5,7-dihydroxytryptamine lesio
Publikováno v:
Pharmacology Biochemistry and Behavior. 44:357-364
Exposure to HBO causes hypothermia, bradycardia, head weaving, resting tremor, piloerection, and straub tail in rats. These physiological and behavioral responses can also be evoked by selective activation of serotonin1A (5-HT1A) receptors. The purpo
Autor:
Patricia A. Broderick
Publikováno v:
Pharmacology, Biochemistry, and Behavior
Pharmacology Biochemistry and Behavior
Pharmacology Biochemistry and Behavior
The effect of subcutaneous (SC) cocaine (20 mg/kg) on synaptic concentrations of the biogenic amines, dopamine (DA), and serotonin (5-HT) in Ventral Tegmental Area, (VTA-[A10]) was studied in freely moving and behaving rats (rattus norvegicus) with i
Autor:
Paul J. Wellman, Becky T. Davies
Publikováno v:
Pharmacology Biochemistry and Behavior. 42:97-100
Phenylpropanolamine (PPA) is a phenethylamine anorectic drug that exerts direct agonist effects predominantly on alpha 1-adrenoceptors, with some alpha 2-adrenergic activity. Microinjections of PPA, as well as the alpha 1-adrenergic receptor agonists